Piezo Motion, Benson Engineering Join Forces to Provide OEMs with Breakthrough Technology
Piezo Motion, Benson Engineering Join Forces to Provide OEMs with Breakthrough Technology
Piezo Motion partners with Benson Engineering to deliver affordable micro-precision motors and motion control solutions to the Southern U.S.
Piezo Motion與Benson Engineering合作，為美國南部地區提供負擔得起的微型精密電機和運動控制解決方案。
LAKEWOOD RANCH, Fla., March 10, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – Piezo Motion, a Brain Scientific (OTCQB:BRSF) company, and Benson Engineering today announce a partnership. Piezo Motion is a developer and leading manufacturer of automation technology. Benson Engineering, founded in 1946, is a family-owned manufacture representative group with offices in Texas and Missouri.
2022年3月10日，佛羅裏達州萊克伍德牧場(Global Newswire)--腦科學公司(OTCQB：BRSF)旗下的Via InvestorWire-Piezo Motion公司今天宣佈與本森工程公司建立合作伙伴關係。Piezo Motion是自動化技術的開發商和領先製造商。本森工程公司成立於1946年，是一家家族製造代表集團，在德克薩斯州和密蘇裏州設有辦事處。
Benson Engineering works primarily with original equipment manufacturers (OEMs) in Texas, Louisiana, Oklahoma, Arkansas, Kansas, Missouri, Nebraska and Iowa. Piezo Motion's multifaceted rotary and linear motors are built with technology that provides a stable, accurate motor that is designed specifically for OEMs that require ultimate speed, size and accuracy.
Benson Engineering主要與德克薩斯州、路易斯安那州、俄克拉何馬州、阿肯色州、堪薩斯州、密蘇裏州、內布拉斯加州和愛荷華州的原始設備製造商(OEM)合作。Piezo Motion的多面旋轉和直線電機採用的技術提供了穩定、精確的電機，該電機是專門為對速度、尺寸和精度要求極高的OEM而設計的。
"We are looking forward to sharing the outstanding Piezo Motion platform with our customer and prospect base, expanding our value proposition with these clients who enjoy and look for next-level upgrades in motion technology," said Alan Hobbs, vice president at Benson Engineering.
本森工程副總裁總裁表示：“我們期待着與我們的客户和潛在客户共享出色的Piezo Motion平臺，與那些喜歡並尋求運動技術下一級升級的客户擴大我們的價值主張。”
Piezo Motion motors are used globally for a variety of applications. These include laboratory instruments, biomedicine, optics, semiconductors, nanotechnology industries, and industrial electronic and automotive systems, along with an expanding portfolio of products that combine performance with dramatically lower cost over conventional piezo solutions.
Piezo Motion馬達在全球範圍內被用於各種應用。這些領域包括實驗室儀器、生物醫學、光學、半導體、納米技術行業以及工業電子和汽車系統，以及不斷擴大的產品組合，這些產品結合了性能和比傳統壓電解決方案低得多的成本。
"Our unique, tiny motors provide unparalleled precision and energy efficiencies to the market," said Hassan Kotob, chairman and CEO of Brain Scientific. "Benson Engineering has been in the industry for more than 75 years and has a stellar reputation. We are looking forward to working with them and providing our precision motors to their customer base at an affordable price."
Brain Science董事長兼首席執行官哈桑·科託布表示：“我們獨特的微型電機為市場提供了無與倫比的精度和能效。”本森工程公司在該行業已有超過75年的歷史，享有極高的聲譽。我們期待着與他們合作，以實惠的價格向他們的客户羣提供我們的精密電機。“
About Piezo Motion
關於Piezo Motion
Piezo Motion (piezomotion.com), a Brain Scientific company, is a leader in precision motor technology with multimillion-dollar investments in research and development of affordable piezoelectric motors to meet, and exceed, the needs of today's global markets. The company is committed to the development of innovative technology and motion products that enhance functionality in a multitude of applications. The company works with startups, OEMs, research institutions and industrial companies from around the world, empowering the visionaries behind their products.
Brain Science旗下的Piezo Motion(Piezomotion.com)是精密電機技術的領先者，在研發負擔得起的壓電式電機方面投資數百萬美元，以滿足並超越當今全球市場的需求。該公司致力於開發創新技術和運動產品，以增強多種應用的功能。該公司與來自世界各地的初創企業、原始設備製造商、研究機構和工業公司合作，為他們產品背後的遠見卓識者賦權。
About Brain Scientific
關於腦科學
Brain Scientific (brainscientific.com) is a medical technology company with multiple patents and FDA-cleared products. Brain Scientific is committed to developing next-gen solutions that advance the future of neurodiagnostic and OEM medical devices. Brain Scientific has two product lines covering neurology and precision motion. The NeuroCap and NeuroEEG are smart neurological diagnostic devices that simplify administration, shorten scan time, and cut costs. The Piezo Motion product line consists of ultra-efficient compact precision motors that will drive the next generation of medical devices. To learn more about Brain Scientific's corporate strategy, products, or investor relations, please visit brainscientific.com.
Brain Science是一家擁有多項專利和FDA批准產品的醫療技術公司。Brain Science致力於開發下一代解決方案，以推動神經診斷和OEM醫療設備的未來。Brain Science有兩個產品線，涵蓋神經學和精密運動。NeuroCap和NeuroEEG是智能神經診斷設備，可以簡化管理、縮短掃描時間並降低成本。Piezo Motion產品線由超高效緊湊型精密電機組成，將驅動下一代醫療設備。欲瞭解有關Brain Science公司的公司戰略、產品或投資者關係的更多信息，請訪問BrainScience網站。
About Benson Engineering
關於本森工程
Benson Engineering (bensonengineering.com) is a third-generation, family-owned, manufacture representative group founded in 1946. For more than 75 years, the company has strived to bring its customers quality products, outstanding service, and ethical standards beyond expectation. Benson Engineering's personnel have all been with the company for a minimum of 20 years each giving long-standing expertise and experience in the territory with many OEMs and distributors.
Benson Engineering(bensonEngineering ering.com)是成立於1946年的第三代家族製造代表性集團。75多年來，公司一直致力於為客户提供優質的產品、卓越的服務和超乎預期的道德標準。Benson Engineering的所有人員都在公司工作了至少20年，每個人都擁有在該地區許多原始設備製造商和分銷商的長期專業知識和經驗。
Forward-Looking Statements
前瞻性陳述
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, statements regarding (i) the plans and objectives of management for future operations, including plans or objectives relating to the design, development and commercialization of EEG products and services and piezo motor technology; (ii) a projection of income (including income/loss), earnings (including earnings/loss) per share, capital expenditures, dividends, capital structure or other financial items; (iii) the company's future financial performance; (iv) the successful integration of Piezo Motion with and into Brain Scientific; and (v) the assumptions underlying or relating to any statement described in points (i), (ii), (iii) or (iv) above. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the company's current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, over many of which the company has no control. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the company's inability to obtain additional financing; the significant length of time and resources associated with the development of products and related insufficient cash flows and resulting illiquidity; the company's inability to expand its business; significant government regulation of medical devices and the healthcare industry; lack of product diversification; volatility in the price of the company's raw materials; and the failure to implement the company's business plans or strategies. Some of these and other factors are identified and described in more detail in the company's filings with the SEC. The company does not undertake to update these forward-looking statements.
本新聞稿中包含的任何不描述歷史事實的陳述都可能構成前瞻性陳述。前瞻性陳述可能包括但不限於以下陳述：(I)未來業務的管理計劃和目標，包括與腦電產品和服務以及壓電電機技術的設計、開發和商業化有關的計劃或目標；(Ii)收入(包括收入/虧損)、每股收益(包括收益/虧損)、資本支出、股息、資本結構或其他財務項目的預測；(Iii)公司未來的財務表現；(Iv)Piezo Motion與Brain Science的成功整合；以及(V)以上第(I)、(Ii)、(Iii)或(Iv)點所述任何陳述所依據的或與之有關的假設。此類前瞻性陳述不是為了預測或保證實際結果、業績、事件或情況，也可能無法實現，因為它們是基於公司目前的預測、計劃、目標、信念、預期、估計和假設，受許多風險、不確定性和其他影響的影響，其中許多是公司無法控制的。由於這些風險和不確定性，某些事件和情況的實際結果和時間可能與前瞻性陳述中描述的大不相同。可能影響或導致前瞻性陳述不準確或導致實際結果與預期或期望結果大不相同的因素可能包括但不限於, 該公司無法獲得更多融資；與開發產品和相關產品相關的時間和資源過長；現金流不足和由此導致的流動性不足；該公司無法擴大其業務；政府對醫療器械和醫療保健行業的監管力度較大；缺乏產品多元化；該公司原材料價格波動；以及未能實施該公司的業務計劃或戰略。在該公司提交給美國證券交易委員會的文件中，對其中一些因素以及其他一些因素進行了識別和更詳細的描述。該公司不承諾更新這些前瞻性陳述。
CONTACTS
觸點
INVESTORS
ir@brainscientific.com
投資商
郵箱：ir@brainScience fic.com
MEDIA
pr@brainscientific.com
媒體
電子郵箱：pr@brainScience fic.com
Corporate Communications
企業通信
IBN (InvestorBrandNetwork)
Los Angeles, California
310.299.1717 Office
Editor@InvestorBrandNetwork.com
IBN(InvestorBrandNetwork)
加利福尼亞州洛杉磯
310.299.1717辦公室
郵箱：EDITOR@InvestorBrandNetwork.com
譯文內容由第三人軟體翻譯。